Stevanato Group’s Post

Are viral vector characterization challenges causing you a headache? Tune in to the viral vector digital symposium to hear from industry experts how they have reclaimed their time and broken through boundaries in their research. Realize the full potential of viral vectors with intuitive, innovative, and informative analytical solutions. Watch on-demand now > https://buff.ly/3UGrE7n SCIEX Biopharma & Pharma Solutions #ViralVectors #Symposium #Vaccines #MassSpectrometry #CapillaryElectrophoresis

Quiz Time!! The COVID-19 vaccines were developed using: a) Weakened virus b) Inactivated virus c) mRNA technology d) Protein subunit To know more about us visit www.jeevanscientific.com #quiz #medicalquiz #medicine #medical #pharmaceuticals #pharma #clinical #clinicaltrials #JSTL #Jeevanscientifictechnologylimited #Jeevanscientific #clinicalresearch

The manufacturing of #COVID-19 vaccines demonstrated how #vaccineproduction can be rapidly scaled up with faster regulatory approval and time to market. Advances in purification technology and analytical tools in recent years has led to an increased market value and manufacturing capacity for vaccines; however, challenges remain. This infographic offers a step-by-step overview of manufacturing and analytical methods for four key #vaccine types: #VLP (virus-like-particle), subunit, #mRNA, and #viralvectorvaccines View below:

We are pleased to share Aktiespararna’s article highlighting Ziccum’s LaminarPace® technology. The article focuses on Ziccum’s great potential when it comes to helping biopharmaceuticals to realization and the mRNA revolution, informative background of the company, current business model and promising market outlook, and information about its recently announced rights issue. Please follow the link to read the full article (in Swedish) here: https://lnkd.in/d4ES9XBr https://lnkd.in/dUjt-Nbf #ziccum #laminarpace #disruptivetechnology #disruptive #innovation #mrna #rna #mrnalnp #lipidnanoparticles #biologics #dryingbiologics #vaccine #formulation #drugformulation #lnpformulation #thermostability #vaccinedelivery #inhalation #inhaledbiologics #particleengineering #carbonfootprint #vaccinedevelopment #drugdevelopment

How High-Pressure Homogenization Contributes to Vaccine Production In the pharmaceutical industry, cutting-edge solutions are essential to ensure maximum efficiency and compliance with strict international regulations. This is particularly true in the production of vaccines, where precision and reliability are paramount.💉 The GEA Pharma Skid high-pressure homogenizers are designed to achieve exceptional results in cell disruption and micronization—critical processes for creating emulsions and dispersions that meet the stringent requirements for intravenous administration, such as those needed for vaccines. Our advanced technologies are now being used to support innovative research in the development of vaccines against various severe diseases, including certain types of cancer and conditions like shingles. While we are still in the early stages, the goal is to develop "tailor-made" vaccines, customized to each patient's specific characteristics and the nature of the disease. This approach aims to increase effectiveness and provide meaningful solutions to countless people worldwide. 📌 These advancements are made possible thanks to GEA’s technology and our unwavering commitment to research, continually delivering innovative and effective solutions for every challenge. #GEA #homogenizer #Pharma #Vaccine #R&D #Innovation #PharmaSkid https://go.gea/3op

Are you developing a vaccine? A comprehensive report on vaccine solutions is now available, providing valuable insights into purification tools for different vaccine types. Learn about successful case studies and innovative chromatography resins designed to help accelerate the downstream purification workflow for vaccines. https://lnkd.in/gnp5DiCz #bioprocessing #bioproduction #vaccines #vaccineproduction #therapeutics #mabs #purification

Are you developing a vaccine? Check out this comprehensive report on vaccine solutions now available! Gain valuable insights into purification tools for different vaccine types. Learn about successful case studies and innovative chromatography resins designed to help accelerate the downstream purification workflow for vaccines. Follow the link to know more: https://lnkd.in/gnp5DiCz #bioprocessing #bioproduction #vaccines #vaccineproduction #therapeutics #mabs #purification

🌟 The Hidden Threat in Biologics: Are Your Manufacturing Processes Safe? 🌟   In biopharmaceutical manufacturing, viral safety is an uncompromising priority. Contamination risks are real, but robust viral clearance strategies ensure safe and effective biologics for patients.   💡 What Makes This Critical? Sources of Contamination: Viruses can originate from human/animal-derived materials or adventitious contamination during manufacturing. Examples include MMV, reovirus, and Cache Valley virus in CHO processes.   Why Clearance Matters: Spiking experiments and scaled-down models replicate full-scale processes to measure viral removal/inactivation—quantified as log10 reductions.   🔬 Technologies & Strategies Chromatography, filtration, and solvent/detergent inactivation are meticulously designed to provide redundancy. Cumulative clearance ensures safety even under worst-case manufacturing conditions.   📋 Regulatory Expectations Early-Stage Trials: Limited data requirements; minimal robustness studies. Licensing Stage: EMA/FDA demand rigorous testing, including aged resins, extended viral panels, and duplicate studies for reproducibility.   ⚠️ The Stakes Are High Undetected or poorly managed viral contamination can result in production delays, economic loss, and patient risks. Comprehensive viral safety measures are not just protocols—they’re a promise of quality and trust.   🚨 Viral safety is the backbone of innovation in biologics. Let’s build safe and effective therapies together.   #Biopharma #ViralSafety #PharmaceuticalInnovation #PatientSafety #Biologics

Are you developing a vaccine? A comprehensive report on vaccine solutions is now available, providing valuable insights into purification tools for different vaccine types. Learn about successful case studies and innovative chromatography resins designed to help accelerate the downstream purification workflow for vaccines. https://lnkd.in/gnp5DiCz #bioprocessing #bioproduction #vaccines #vaccineproduction #therapeutics #mabs #purification

Are you developing a vaccine? A comprehensive report on vaccine solutions is now available, providing valuable insights into purification tools for different vaccine types. Learn about successful case studies and innovative chromatography resins designed to help accelerate the downstream purification workflow for vaccines. https://lnkd.in/gnp5DiCz #bioprocessing #bioproduction #vaccines #vaccineproduction #therapeutics #mabs #purification